| Patient Percentage (%) |
---|---|
Demographic | |
 Male | 50.4 |
 Type 1 Diabetes Mellitus | 7.37 |
Comorbidities | |
 Hypertension | 35.6 |
 Ophthalmological Complications | 32.2 |
 Ischemic Heart Disease | 16.2 |
 Ischemic Stroke and Transient Ischemic Attack | 11.8 |
 Heart Failure | 9.8 |
 Chronic Renal Disease | 8.8 |
 Chronic Liver Disease | 5.8 |
 Acute Myocardial Infarction | 5.1 |
 Chronic Obstructive Pulmonary Disease | 3.5 |
Anti-diabetic Medication | |
 Biguanide | 57.6 |
 Sulphonylurea | 41.5 |
 Thiazolidinedione | 3.5 |
 Alpha-Glucosidase | 3.0 |
 Dipeptidyl Peptidase-4 Inhibitor | 0.4 |
 Glucagon-Like Peptide-1 Receptor Agonist | < 0.1 |
Cardiovascular medication | |
 Angiotensinogen-Converting Enzyme Inhibitor/ Angiotensin-Receptor Blocker | 59.8 |
 Calcium Channel Blocker | 43.6 |
 Lipid-Lowering Agents | 42.4 |
 Aspirin | 36.2 |
 Diuretic | 29.2 |
 Beta-Adrenergic Receptor Blocker | 28.1 |